Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

640 ARTÍCULOS , VIENDO DEL 181 AL 195

Alzheimer's disease: risk factors and potentially protective measures

Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG.

J Biomed Sci. 2019 May 9;26(1):33. doi: 10.1186/s12929-019-0524-y.

Mood, lifestyle and cardiovascular risk factors among older caregivers of patients with Alzheimer's disease dementia: a case-control study

Madaleno TR, Moriguti JC, Ferriolli E, De Carlo MMRP, Lima NKC.

Aging Clin Exp Res. 2019 Nov;31(11):1609-1614. doi: 10.1007/s40520-019-01212-8. Epub 2019 May 9.

Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment

Wu A, Sharrett AR, Gottesman RF, Power MC, Mosley TH Jr, Jack CR Jr, Knopman DS, Windham BG, Gross AL, Coresh J.

JAMA Netw Open. 2019 May 3;2(5):e193359. doi: 10.1001/jamanetworkopen.2019.3359.

A metabolic perspective of late onset Alzheimer's disease

Ettcheto M, Cano A, Busquets O, Manzine PR, Sánchez-López E, Castro-Torres RD, Beas-Zarate C, Verdaguer E, García ML, Olloquequi J, Auladell C, Folch J, Camins A.

Pharmacol Res. 2019 Jul;145:104255. doi: 10.1016/j.phrs.2019.104255. Epub 2019 May 7.

Hospital readmission in persons with dementia: A systematic review

Ma C, Bao S, Dull P, Wu B, Yu F.

Int J Geriatr Psychiatry. 2019 Aug;34(8):1170-1184. doi: 10.1002/gps.5140. Epub 2019 May 20.

Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension

de Heus RAA, Donders R, Santoso AMM, Olde Rikkert MGM, Lawlor BA, Claassen JAHR; Nilvad Study Group.

J Am Heart Assoc. 2019 May 21;8(10):e011938. doi: 10.1161/JAHA.119.011938.

Challenges of hypertension and dementia in the Indian subcontinent: a review

Nair T.

J Hum Hypertens. 2019 Aug;33(8):568-574. doi: 10.1038/s41371-019-0205-z. Epub 2019 May 14.

Intravenous immunoglobulins for Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease: A systematic review with meta-analysis

Liu J, Wang LN.

Expert Rev Neurother. 2019 Jun;19(6):475-480. doi: 10.1080/14737175.2019.1620106. Epub 2019 May 23.

Neuronal Intranuclear Inclusion Disease: A Rare Etiology for Rapidly Progressive Dementia

Yadav N, Raja P, Shetty SS, Jitender S, Prasad C, Kamble NL, Mahadevan A, M N.

Alzheimer Dis Assoc Disord. 2019 Oct-Dec;33(4):359-361. doi: 10.1097/WAD.0000000000000312.

Development of Alzheimer disease in old major depressive patients based upon their health status: A retrospective study in Taiwan

Tao P, Yang SN, Tung YC, Yang MC.

Medicine (Baltimore). 2019 May;98(20):e15527. doi: 10.1097/MD.0000000000015527.

Is poor health literacy a risk factor for dementia in older adults? Systematic literature review of prospective cohort studies

Oliveira D, Bosco A, di Lorito C.

Maturitas. 2019 Jun;124:8-14. doi: 10.1016/j.maturitas.2019.03.010. Epub 2019 Mar 15.

Prevention and Treatment of Alzheimer's Disease: Biological Mechanisms of Exercise

McGurran H, Glenn JM, Madero EN, Bott NT.

J Alzheimers Dis. 2019;69(2):311-338. doi: 10.3233/JAD-180958.

Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review

Bucci T, Menichelli D, Pignatelli P, Triggiani M, Violi F, Pastori D.

J Alzheimers Dis. 2019;69(2):561-576. doi: 10.3233/JAD-181294.

Reducing the risk of dementia

The Lancet.

Lancet. 2019 May 18;393(10185):2009. doi: 10.1016/S0140-6736(19)31085-2.

Therapeutic perspective on vascular cognitive impairment

Toyama K, Spin JM, Mogi M, Tsao PS.

Pharmacol Res. 2019 Aug;146:104266. doi: 10.1016/j.phrs.2019.104266. Epub 2019 May 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias